Endurant Capital Management LP Iovance Biotherapeutics, Inc. Transaction History

Endurant Capital Management LP

$0
Q1 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$5.53 - $8.22 $54,194 - $80,556	9,800 Added 13.87%	80,455 $491,000
Q4 2022 Feb 14, 2023	BUY	$5.62 - $10.0 $397,081 - $706,550	70,655 New	70,655 $451,000
Q2 2022 Aug 15, 2022	SELL	$6.38 - $18.33 $387,393 - $1.11 Million	-60,720 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$12.38 - $19.1 $83,428 - $128,714	6,739 Added 12.48%	60,720 $1.01 Million
Q4 2021 Feb 14, 2022	SELL	$16.55 - $27.63 $1.28 Million - $2.13 Million	-77,117 Reduced 58.82%	53,981 $1.03 Million
Q3 2021 Nov 15, 2021	SELL	$20.35 - $26.63 $595,522 - $779,300	-29,264 Reduced 18.25%	131,098 $3.23 Million
Q2 2021 Aug 16, 2021	SELL	$16.33 - $33.07 $2.45 Million - $4.97 Million	-150,287 Reduced 48.38%	160,362 $4.17 Million
Q1 2021 May 17, 2021	BUY	$28.67 - $52.59 $7.35 Million - $13.5 Million	256,428 Added 472.93%	310,649 $9.84 Million
Q4 2020 Feb 16, 2021	BUY	$28.04 - $50.26 $1.52 Million - $2.73 Million	54,221 New	54,221 $2.52 Million
Q2 2020 Aug 14, 2020	SELL	$27.21 - $41.0 $549,832 - $828,487	-20,207 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$19.54 - $38.85 $2.9 Million - $5.76 Million	-148,339 Reduced 88.01%	20,207 $605,000
Q4 2019 Feb 14, 2020	BUY	$17.95 - $29.41 $1.48 Million - $2.43 Million	82,477 Added 95.83%	168,546 $4.67 Million
Q3 2019 Nov 14, 2019	SELL	$17.99 - $26.0 $1.57 Million - $2.27 Million	-87,169 Reduced 50.32%	86,069 $1.57 Million
Q2 2019 Aug 14, 2019	BUY	$9.78 - $24.52 $1.69 Million - $4.25 Million	173,238 New	173,238 $4.25 Million
Q1 2019 May 15, 2019	SELL	$8.41 - $11.26 $2.68 Million - $3.58 Million	-318,185 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$7.51 - $11.93 $570,880 - $906,870	76,016 Added 31.39%	318,185 $2.82 Million
Q3 2018 Nov 14, 2018	BUY	$11.25 - $17.7 $2.72 Million - $4.29 Million	242,169 New	242,169 $2.72 Million

Others Institutions Holding IOVA

# of Institutions

320

Shares Held

238M

Call Options Held

1.27M

Put Options Held

1.68M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.74B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Endurant Capital Management LP with notifications on news.

Account